Benlysta and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Benlysta (belimumab), especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Osteoporosis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Benlysta. It is created by eHealthMe based on reports of 23,452 people who have side effects when taking Benlysta from the FDA, and is updated regularly.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,493 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 13, 2026

23,452 people reported to have side effects when taking Benlysta.
Among them, 21 people (0.09%) have Visual acuity reduced.

Could Benlysta cause Visual acuity reduced?

Among these 21 people:

How long have people been on Benlysta when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Benlysta? *

female: 100 %
male: 0.0 %

What is the age of people who have Visual acuity reduced when taking Benlysta? *

What are other drugs people take besides Benlysta? *

What are other side effects people have besides Visual acuity reduced? *

Drug Ineffective: 10 people, 47.62%
The Flu (the flu is caused by an influenza virus): 7 people, 33.33%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 33.33%
Visual Impairment: 6 people, 28.57%
Pain: 6 people, 28.57%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 5 people, 23.81%
Memory Loss: 5 people, 23.81%
Headache (pain in head): 5 people, 23.81%
Diarrhea: 5 people, 23.81%
Infection: 5 people, 23.81%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 4 people, 19.05%
Pain: 2 people, 9.52%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 4.76%
Depression: 1 person, 4.76%
Central Nervous System Inflammation (infection of brain or spinal cord): 1 person, 4.76%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Benlysta and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benlysta:

Benlysta (23,528 reports)

Browse all side effects of Benlysta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,493 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on belimumab (the active ingredients of Benlysta) and Benlysta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.